Gene therapy for type 1 diabetes aims to eliminate daily insulin injections
Researchers at the University of Wisconsin School of Medicine and Public Health are one step closer to developing a gene therapy for Type 1 diabetes mellitus – a development that could one day eliminate the need for daily insulin shots and provide a way to better regulate glucose metabolism, a factor critical for preventing the most problematic complications of the disease.
Daniel Resnick chosen to lead the North American Spine Society
UW Health spine surgeon Dr. Daniel Resnick was elected president of the 8,000-member North American Spine Society at its annual meeting this month.
Alan Rapraeger awarded $1.9 million grant to study myeloma cell signaling
Alan Rapraeger, MD, professor of human oncology at the University of Wisconsin School of Medicine and Public Health, has been awarded a five-year, $1.9 million R01 grant from the National Cancer Institute to investigate signaling mechanisms that drive myeloma cell proliferation, survival and invasion.
New study shows how cells can be led down non-cancer path
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells.
Study finds people with Alzheimer’s disease have altered gut bacteria
Changes in gut bacteria could be linked to Alzheimer’s disease, according to a new study from the University of Wisconsin School of Medicine and Public Health.
Rebecca Minter named surgery chair
Dr. Rebecca Minter will become the next chair of the department of surgery at the University of Wisconsin School of Medicine and Public Health.
Study shows HPV works across cellular borders to drive cervical cancer
Human papillomavirus (HPV) and the hormone estrogen are both linked to the development of cervical cancers, but how they work together has remained unclear.
Zachary Morris earns prestigious NIH Director’s Early Independence Award
The National Institutes of Health (NIH) announced that Dr. Zachary Morris has been awarded $1.25 million as part of the NIH Director’s Early Independence Award.
Study identifies patients who benefit most from dinutuximab-based immunotherapy
Using data from a randomized phase III clinical trial of neuroblastoma patients (treated with or without immunotherapy) performed by the Children’s Oncology Group, researchers from the University of Wisconsin School of Medicine and Public Health found that a subset of patients, identified by the presence of a certain set of genes, were more likely to benefit from the immunotherapy than those patients that did not have that set of genes.
New leadership for revamped student research office
In an effort to enhance support for student research, the Office of Health Professional Student Research was created within the Office of Academic Affairs, and to kick things off, it has named its leadership team.
Researchers discover how two gene enhancers control blood cell development
A group of researchers from the University of Wisconsin School of Medicine and Public Health (SMPH) has unearthed a critical process in how healthy red blood cells are produced.
David Bernhardt honored by the American Academy of Pediatrics
David Bernhardt, MD, professor of pediatrics and orthopedics and rehabilitation at the University of Wisconsin School of Medicine and Public Health, was named the 2017 recipient of the Thomas E. Shaffer Fellow of the American Academy of Pediatrics Award.